tiprankstipranks
Advertisement
Advertisement
Eikon Therapeutics price target lowered to $32 from $34 at BofA
PremiumThe FlyEikon Therapeutics price target lowered to $32 from $34 at BofA
2M ago
Premium
Company Announcements
Eikon Highlights Promising New Clinical Data in Oncology
2M ago
Eikon Therapeutics presents data on lead programs at ASCO 2026
Premium
The Fly
Eikon Therapeutics presents data on lead programs at ASCO 2026
2M ago
Eikon Therapeutics initiated with an Overweight at Cantor Fitzgerald
PremiumThe FlyEikon Therapeutics initiated with an Overweight at Cantor Fitzgerald
5M ago
Eikon Therapeutics initiated with a Buy at BofA
Premium
The Fly
Eikon Therapeutics initiated with a Buy at BofA
5M ago
Eikon Therapeutics initiated with an Outperform at Mizuho
Premium
The Fly
Eikon Therapeutics initiated with an Outperform at Mizuho
5M ago
Eikon Therapeutics initiated with an Underperform at Wedbush
PremiumThe FlyEikon Therapeutics initiated with an Underperform at Wedbush
5M ago
Opening Day: SpyGlass Pharma soars in debut after strongly priced IPO
Premium
The Fly
Opening Day: SpyGlass Pharma soars in debut after strongly priced IPO
6M ago
Premium
Company Announcements
Eikon Therapeutics completes IPO and updates governance documents
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100